Amplified Sciences achieves CAP accreditation for cutting-edge diagnostic lab

Gold standard milestone clears the path for national expansion of PanCystPro™ assay

2026-02-27

(Press-News.org) WEST LAFAYETTE, Ind. and IRVINE, Calif. — Amplified Sciences, a diagnostics life sciences company revolutionizing early disease detection, today announced that its clinical laboratory has been awarded accreditation by the College of American Pathologists (CAP).

CEO and co-founder Diana Caldwell said the gold standard recognition follows the company laboratory’s 2025 federal CLIA certification.

“It marks a critical milestone in the commercial scaling of PanCystPro™, our lead assay for pancreatic cancer risk stratification,” she said.

About the accreditation

Caldwell said the CAP Laboratory Accreditation Program is widely considered the most stringent in the world, designed to ensure the highest standard of care for all patients. To earn accreditation, Amplified Sciences’ lab underwent a rigorous on-site inspection of its clinical protocols, staff qualifications, equipment, safety programs and overall management.

“While our CLIA certification gave us the license to operate, CAP accreditation gives our clinical partners the license to trust,” she said. “Achieving this benchmark is not just a regulatory check mark; it is a testament to our team’s commitment to quality as we roll out PanCystPro to leading health care systems, starting with our early access program at the University of California, San Francisco.”

“The CAP is pleased to recognize Amplified Sciences as meeting the high standard set as part of the CAP’s Laboratory Accreditation Program,” said Earle S. Collum, MD, FCAP, chair of the CAP’s Council on Accreditation. “Amplified Sciences joins the thousands of others that are committed to raising the quality of laboratory services nationally and internationally.”

Amplified Sciences’ precision diagnostics

Caldwell said the newly accredited laboratory performs the PanCystPro assay, which utilizes the company’s proprietary BioMatra™ optical reporter platform.

“By combining multiomics science with proprietary computation algorithms, PanCystPro helps clinicians accurately rule out malignancy in pancreatic cystic lesions with over 95% negative predictive value,” she said. “This precision allows many patients to avoid unnecessary, high-risk surgery while identifying those who need monitoring or intervention.”

V. Jo Davisson said CAP accreditation further validates the clinical readiness of the company’s unique protease turnover assays. He is the chief scientific officer at Amplified Sciences, a professor of medicinal chemistry and molecular pharmacology in Purdue University’s College of Pharmacy, and a member of the Purdue Institute for Cancer Research and the Purdue Institute for Drug Discovery.

“By maintaining these elite standards, we ensure that every microliter of patient sample analyzed in our lab provides the reliable, biological insight necessary to address one of the world’s deadliest cancers,” he said.

He disclosed the intellectual property through the Purdue Innovates Office of Technology Commercialization. OTC executed an exclusive license with Amplified Sciences for the global suite of patents.

Amplified Sciences is a Purdue Innovates Ventures portfolio company. Ventures most recently supported Amplified Sciences with an investment in the company’s $2.6 million Series Seed Preferred capital raise in 2023.

About Amplified Sciences

Amplified Sciences is a life science diagnostics company focused on providing innovative tests that enable earlier detection, risk stratification and monitoring of serious diseases. Leveraging an ultra-sensitive optical reporter platform licensed from Purdue University, the company is headquartered in West Lafayette, Indiana, with its CAP-accredited and CLIA-certified clinical lab located in Irvine, California. To learn more, visit amplifiedsciences.com.

About Purdue Innovates Office of Technology Commercialization

The Purdue Innovates Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university’s academic activities through commercializing, licensing and protecting Purdue intellectual property. In fiscal year 2025, the office reported 161 deals executed with 269 technologies licensed, 479 invention disclosures received, and 267 U.S. and international patents received. The office is managed by the Purdue Research Foundation, a private, nonprofit foundation created to advance the mission of Purdue University. Contact otcip@prf.org for more information.

About Purdue University

Purdue University is a public research university leading with excellence at scale. Ranked among top 10 public universities in the United States, Purdue discovers, disseminates and deploys knowledge with a quality and at a scale second to none. More than 106,000 students study at Purdue across multiple campuses, locations and modalities, including more than 57,000 at our main campus locations in West Lafayette and Indianapolis. Committed to affordability and accessibility, Purdue’s main campus has frozen tuition 14 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap — including its integrated, comprehensive Indianapolis urban expansion; the Mitch Daniels School of Business; Purdue Computes; and the One Health initiative — at https://www.purdue.edu/president/strategic-initiatives.

Media contact: Diana Caldwell, diana.caldwell@amplifiedsci.com

END

ELSE PRESS RELEASES FROM THIS DATE:

Fred Hutch announces 12 recipients of the annual Harold M. Weintraub Graduate Student Award

2026-02-27

SEATTLE — Feb. 26, 2026 — Fred Hutch Cancer Center announced 12 recipients of the Harold M. Weintraub Graduate Student Award, which honors the exceptional achievements of graduate students in the biological sciences. Representing research institutions across the United States, this year’s award recipients explored a range of scientific topics including tumor metabolism, sensory reception and DNA replication. “These awardees stood out for their scientific originality, rigor and dedication to asking important scientific questions. They reflect the strength and promise of the next generation of scientific leaders,” said Jihong Bai, PhD, a professor in Fred ...

Native forest litter helps rebuild soil life in post-mining landscapes

2026-02-27

Restoring ecosystems after mining is one of the toughest environmental challenges, particularly when soils are rebuilt from crushed rock with little organic matter or microbial life. A new study shows that something as simple as adding native forest litter could jump-start soil recovery and help restore the biological engine that drives nutrient cycling. Researchers investigating rehabilitated land near a former uranium mine in northern Australia found that introducing leaf litter from nearby native Eucalyptus woodlands rapidly reshaped soil microbial communities and improved their functional potential. The findings ...

Mountain soils in arid regions may emit more greenhouse gas as climate shifts, new study finds

2026-02-27

A new field study from northwestern China reveals that climate-driven changes in temperature and moisture could significantly reshape nitrous oxide emissions from soils in arid mountain ecosystems, with important implications for future climate feedbacks. Nitrous oxide is a powerful greenhouse gas that traps nearly 300 times more heat than carbon dioxide over a century. Although drylands cover roughly 40 percent of the Earth’s land surface, their contribution to global nitrous oxide emissions has been poorly understood. The new research helps fill this gap by examining how soil emissions vary across elevation and land-use types in the Xinjiang region of China. Researchers ...

Pairing biochar with other soil amendments could unlock stronger gains in soil health

2026-02-27

A growing body of research suggests that combining biochar with other soil amendments such as compost, manure, or fertilizers may improve soil health more effectively than using biochar alone. A new review synthesizing field studies from around the world shows that this co-application approach can enhance soil structure, nutrient availability, and microbial activity, offering a promising strategy for sustainable land management. Biochar is a carbon-rich material produced by heating biomass in low-oxygen conditions. It has gained attention ...

Why do we get a skip in our step when we’re happy? Thank dopamine

2026-02-27

New research by engineers at the University of Colorado Boulder aims to get to the bottom of why, as the saying goes, you get a “skip in your step” when you’re happy. The study highlights the central role that dopamine, a brain chemical associated with reward, seems to play in making people move faster when they want something. The findings could one day help scientists understand and even diagnose a range of human medical conditions, including Parkinson’s disease and depression. “Anecdotally, we just feel that this is true,” said senior author Alaa Ahmed, professor in the Paul M. Rady Department of Mechanical Engineering at CU Boulder. ...

UC Irvine scientists uncover cellular mechanism behind muscle repair

2026-02-27

Irvine, Calif., Feb. 27, 2026 — Scientists at the University of California, Irvine’s School of Pharmacy & Pharmaceutical Sciences have discovered how muscle stem cells “flip a switch” to rebuild damaged muscle – a finding that could help address muscle loss linked to aging, injury and widely used weight-loss medications. The study, published this week in Nature Metabolism, shows that muscle recovery is not just about protein or exercise. It depends on timing and how muscle cells use fuel. Researchers learned that immediately after ...

Platform to map living brain noninvasively takes next big step

2026-02-27

HOUSTON – (Feb. 27, 2026) – Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, hemophilia and, recently, Huntington’s disease, a fatal neurological disorder. An advance reported in the journal Neuron adds to the technique’s growing track record of evidence supporting the view that it could unlock powerful, personalized therapies: Rice University bioengineer Jerzy Szablowski and collaborators in Vincent Costa’s lab at Emory University found that released markers of activity (RMAs) ⎯ engineered proteins designed to cross the blood-brain barrier and persist in the blood for ...

Stress-testing the Cascadia Subduction Zone reveals variability that could impact how earthquakes spread

2026-02-27

The Cascadia Subduction Zone is unusually quiet for a megathrust fault. Spanning more than 600 miles from Canada to California, the fault marks the convergence of the Juan de Fuca and North American plates. While other subduction zones produce sporadic rumblings as the plates scrape past each other, Cascadia shows very little seismic activity, fueling assumptions that the plates are locked together by friction. The subduction zone — miles offshore and deep underwater — is difficult to observe. Most data collection ...

We may be underestimating the true carbon cost of northern wildfires

2026-02-27

Wildfires in the northern boreal forests of Alaska, Canada, Scandinavia and Russia may be more damaging to the climate than previously thought, a new UC Berkeley-led study suggests. That’s because these fires don’t just burn through trees; they can also penetrate deep into the carbon-rich layers of soil underneath many boreal forests, releasing carbon that has been accumulating for hundreds or even thousands of years. These carbon-rich soils, also known as peat, are primarily found in the far north, where the cold, wet climate prevents vegetation from fully decomposing ...

Blood test predicts which bladder cancer patients may safely skip surgery

2026-02-27

Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant chemoimmunotherapy can be considered in select patients. The ctDNA blood test predicts metastatic risk, but not local recurrence, after bladder-sparing cancer treatment. Researchers said ctDNA could be used to help select patients likely to benefit from a bladder-sparing treatment approach. A combination of chemotherapy and immunotherapy allowed some patients to preserve ...

Amplified Sciences achieves CAP accreditation for cutting-edge diagnostic lab

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: